Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2017-2028)
2.2 Insomnia Therapy Growth Trends by Region
2.2.1 Insomnia Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Insomnia Therapy Historic Market Size by Region (2017-2022)
2.2.3 Insomnia Therapy Forecasted Market Size by Region (2023-2028)
2.3 Insomnia Therapy Market Dynamics
2.3.1 Insomnia Therapy Industry Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Revenue
3.1.1 Global Top Insomnia Therapy Players by Revenue (2017-2022)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2021
3.5 Insomnia Therapy Key Players Head office and Area Served
3.6 Key Players Insomnia Therapy Product Solution and Service
3.7 Date of Enter into Insomnia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2017-2022)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2023-2028)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2017-2022)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Insomnia Therapy Market Size (2017-2028)
6.2 North America Insomnia Therapy Market Size by Type
6.2.1 North America Insomnia Therapy Market Size by Type (2017-2022)
6.2.2 North America Insomnia Therapy Market Size by Type (2023-2028)
6.2.3 North America Insomnia Therapy Market Share by Type (2017-2028)
6.3 North America Insomnia Therapy Market Size by Application
6.3.1 North America Insomnia Therapy Market Size by Application (2017-2022)
6.3.2 North America Insomnia Therapy Market Size by Application (2023-2028)
6.3.3 North America Insomnia Therapy Market Share by Application (2017-2028)
6.4 North America Insomnia Therapy Market Size by Country
6.4.1 North America Insomnia Therapy Market Size by Country (2017-2022)
6.4.2 North America Insomnia Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2017-2028)
7.2 Europe Insomnia Therapy Market Size by Type
7.2.1 Europe Insomnia Therapy Market Size by Type (2017-2022)
7.2.2 Europe Insomnia Therapy Market Size by Type (2023-2028)
7.2.3 Europe Insomnia Therapy Market Share by Type (2017-2028)
7.3 Europe Insomnia Therapy Market Size by Application
7.3.1 Europe Insomnia Therapy Market Size by Application (2017-2022)
7.3.2 Europe Insomnia Therapy Market Size by Application (2023-2028)
7.3.3 Europe Insomnia Therapy Market Share by Application (2017-2028)
7.4 Europe Insomnia Therapy Market Size by Country
7.4.1 Europe Insomnia Therapy Market Size by Country (2017-2022)
7.4.2 Europe Insomnia Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size (2017-2028)
8.2 Asia-Pacific Insomnia Therapy Market Size by Type
8.2.1 Asia-Pacific Insomnia Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Insomnia Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Insomnia Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Insomnia Therapy Market Size by Application
8.3.1 Asia-Pacific Insomnia Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Insomnia Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Insomnia Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Insomnia Therapy Market Size by Region
8.4.1 Asia-Pacific Insomnia Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Insomnia Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Insomnia Therapy Market Size (2017-2028)
9.2 Latin America Insomnia Therapy Market Size by Type
9.2.1 Latin America Insomnia Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Insomnia Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Insomnia Therapy Market Share by Type (2017-2028)
9.3 Latin America Insomnia Therapy Market Size by Application
9.3.1 Latin America Insomnia Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Insomnia Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Insomnia Therapy Market Share by Application (2017-2028)
9.4 Latin America Insomnia Therapy Market Size by Country
9.4.1 Latin America Insomnia Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Insomnia Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size (2017-2028)
10.2 Middle East & Africa Insomnia Therapy Market Size by Type
10.2.1 Middle East & Africa Insomnia Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Insomnia Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Insomnia Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Insomnia Therapy Market Size by Application
10.3.1 Middle East & Africa Insomnia Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Insomnia Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Insomnia Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Insomnia Therapy Market Size by Country
10.4.1 Middle East & Africa Insomnia Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Insomnia Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2017-2022)
11.1.5 Merck & Co. Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2017-2022)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Details
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2017-2022)
11.5.5 Purdue Pharmaceuticals L.P. Recent Developments
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Details
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2017-2022)
11.6.5 Eisai, Co. Ltd. Recent Developments
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Details
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2017-2022)
11.7.5 Meda Consumer Healthcare Recent Developments
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2017-2022)
11.8.5 Pernix Therapeutics Recent Developments
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Details
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022)
11.9.5 Vanda Pharmaceuticals Recent Developments
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Details
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022)
11.10.5 ECR Pharmaceuticals Recent Developments
11.11 Fidia Farmaceutici
11.11.1 Fidia Farmaceutici Company Details
11.11.2 Fidia Farmaceutici Business Overview
11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2017-2022)
11.11.5 Fidia Farmaceutici Recent Developments
11.12 Dainippon Sumitomo
11.12.1 Dainippon Sumitomo Company Details
11.12.2 Dainippon Sumitomo Business Overview
11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2017-2022)
11.12.5 Dainippon Sumitomo Recent Developments
11.13 Biocodex
11.13.1 Biocodex Company Details
11.13.2 Biocodex Business Overview
11.13.3 Biocodex Insomnia Therapy Introduction
11.13.4 Biocodex Revenue in Insomnia Therapy Business (2017-2022)
11.13.5 Biocodex Recent Developments
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Insomnia Therapy Introduction
11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2017-2022)
11.14.5 Eli Lilly and Company Recent Developments
11.15 Ebb Therapeutics
11.15.1 Ebb Therapeutics Company Details
11.15.2 Ebb Therapeutics Business Overview
11.15.3 Ebb Therapeutics Insomnia Therapy Introduction
11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2017-2022)
11.15.5 Ebb Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer